Erik van Muilekom
Papers
12
Total Citations
346
H-Index
9
About
Erik van Muilekom is a urological researcher whose work has significantly advanced the understanding and practice of robot-assisted laparoscopic prostatectomy (RALP) and prostate cancer management. His research spans surgical technique optimization, lymph node staging, quality of life outcomes, and emerging diagnostic technologies, making him a well-rounded contributor to the field of urological oncology. Among his most influential contributions, van Muilekom's 2010 prospective trial on posterior musculofascial reconstruction demonstrated meaningful improvements in early continence recovery following RALP, accumulating 80 citations and influencing surgical technique refinements worldwide. His 2019 study combining PSMA PET/CT with sentinel node biopsy (54 citations) helped define a more precise approach to primary lymph node staging in prostate cancer patients. Earlier work examining nodal dissection outcomes across 440 RALP cases (44 citations) provided critical insight into the learning curve and procedural consistency across surgeons. Van Muilekom has also made notable contributions to patient-centered research, comparing quality of life across brachytherapy, RALP, and active surveillance (36 citations), and more recently investigating financial toxicity following prostatectomy. His body of work reflects a commitment to both technical excellence and holistic patient outcomes, offering valuable guidance to clinicians navigating complex prostate cancer treatment decisions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10